The Cold Urticaria Activity Score (ColdUAS) is the first instrument for assessing disease activity in patients with cold urticaria (ColdU). The questionnaire is simple and user-friendly, designed for adults and adolescents 12 years and older. The ColdUAS was developed by a team of urticaria experts at Charité University, led by PD Dr. Dorothea Terhorst-Molawi, PD Dr. Karsten...

The Cold Urticaria Activity Score (ColdUAS) is the first instrument for assessing disease activity in patients with cold urticaria (ColdU). The questionnaire is simple and user-friendly, designed for adults and adolescents 12 years and older. The ColdUAS was developed by a team of urticaria experts at Charité University, led by PD Dr. Dorothea Terhorst-Molawi, PD Dr. Karsten...

The Quality of Life Questionnaire for Patients with Cold Urticaria (ColdU-QoL) is the first and so far only quality of life questionnaire developed specifically for patients with cold urticaria. The ColdU-QoL is easy to use and evaluate. The ColdU-QoL was developed at the Charité by a team led by Dr. Karsten Weller and Dr. Marcus Maurer. Quick Facts ColdU-QoL: Number of...

The Quality of Life Questionnaire for Patients with Cold Urticaria (ColdU-QoL) is the first and so far only quality of life questionnaire developed specifically for patients with cold urticaria. The ColdU-QoL is easy to use and evaluate. The ColdU-QoL was developed at the Charité by a team led by Dr. Karsten Weller and Dr. Marcus Maurer. Quick Facts ColdU-QoL: Number of...

FricTest® is a device for the qualitative and semiquantitative diagnosis of symptomatic dermographism.

The Mastocytosis Quality of Life Questionnaire (MC-QoL) is the first and only mastocytosis-specific quality of life (QoL) questionnaire available so far. It is a short, valid and reliable instrument to determine QoL impairment in patients with cutaneous and indolent systemic mastocytosis. MC-QoL was developed by a Charité team of scientists led by PD Dr. Frank Siebenhaar, PD...

The Mastocytosis Quality of Life Questionnaire (MC-QoL) is the first and only mastocytosis-specific quality of life (QoL) questionnaire available so far. It is a short, valid and reliable instrument to determine QoL impairment in patients with cutaneous and indolent systemic mastocytosis. MC-QoL was developed by a Charité team of scientists led by PD Dr. Frank Siebenhaar, PD...

The Mastocytosis Control Test (MCT) is an easy-to-use disease-specific tool to assess disease control in patients with cutaneous or indolent systemic mastocytosis. The MCT is a retrospective tool and can be used directly, quickly, and easily during patient presentation. A cut off value helps distinguish patients with poorly controlled disease from patients with...

The Mastocytosis Control Test (MCT) is an easy-to-use disease-specific tool to assess disease control in patients with cutaneous or indolent systemic mastocytosis. The MCT is a retrospective tool and can be used directly, quickly, and easily during patient presentation. A cut off value helps distinguish patients with poorly controlled disease from patients with...

This questionnaire for assessing disease activity in patients with cutaneous and indolent systemic mastocytosis is a symptom questionnaire that was specially developed for patients with mastocytosis. The Mastocytosis Activity Score (MAS) is easy to use and has been validated for patients with cutaneous and indolent systemic mastocytosis. The MAS was developed at Charité by a...

This questionnaire for assessing disease activity in patients with cutaneous and indolent systemic mastocytosis is a symptom questionnaire that was specially developed for patients with mastocytosis. The Mastocytosis Activity Score (MAS) is easy to use and has been validated for patients with cutaneous and indolent systemic mastocytosis. The MAS was developed at Charité by a...

The Prurigo Control Test (PCT) is a validated, user-friendly designed instrument to assess disease control in patients with chronic prurigo. The PCT is a retrospective instrument and can be evaluated directly, quickly and easily. Its cut-off value of 11 points helps to distinguish patients with poorly controlled chronic prurigo from patients with well-controlled disease. The...